Good to know

A closer look at the function and efficicacy of niraparib as a maintenace treatment.

There are a number of medicines available for melanoma patients. In this article we examine one newer medicine and discuss it's efficacy and use. 

 

The European Medicines Agency has recently approved Niraparib (Zejula) for use in the European Union as a treatment for women struggling with a specific type of advanced ovarian cancer known as high-grade serous epithelial ovarian cancer, which includes cancers that affect the peritoneum and/or the fallopian tubes.

 

When a new medicine gets approved for use and for sale in a specific region, it’s usually given a brand name by the pharmaceutical company who discovered or developed it.

In 2015, an estimated 221,200 people in the U.S. will be diagnosed with lung cancer, which is 13 percent of all cancer diagnoses.

We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...

Why every little package is a big deal

How effective is alectinib (Alecensa)? The latest news and updates

 We live in an age where you can hop online to order a new brand of lipstick if it hasn’t been released yet in your country. 

Suggestions from cancer survivors and their children

Online counsellor Nicole Hind shares how to help our brains and bodies deal with a diagnosis.

An easy-to-understand infographic displaying the results from the clinical trial

For US patients and patients worldwide with ALS.

What did we get up to, and what's next?

Get the latest news on MS research, the FDA approval of Ocrevus (ocrelizumab) for both relapsing and progressive forms of MS, insights and resources.